• Freezevacx Introduces Vaccine Freezers for Aircrafts - One of the industries that have suffered immense setbacks to the tune of the negative effects of Covid-19 pandemic in the globe is the logistics industry. Apart from the lockdown and the suspension of air travel imposed on airlines by almost every countries of the world, major transportation companies and agencies are being under huge scrutiny to ensure that the right steps are taken towards halting the spread and cross contamination of this virus even after the coronavirus virus lockdown and ban on air travels was lifted. One of the most virally suggested prevention method since this time is disinfection. To this end, companies like VirusGuard has researched and manufactured high performing and real-time disinfection products, which do not only clean contactable surfaces of transport vehicles and airplane interiors, but are also useful to ensure high quality hygiene against all sort of bacteria, virus and fungal infections in homes, schools and industries. These products are simply made in several production categories to ensure efficiency based on the scope and place of use. More than disinfectants, vaccines have been developed as health aids and preventions against coronavirus and other possible infections. However, some of these products have short lifespan while others wouldn’t retain their efficiency under certain conditions of use and transportation. Since both concerned government agencies and private investment holders in the world have been trying to help aviation get back to its healthy state, lots of steps are being taken to ensure that air travel gets back to its safe and secured state. Accepting that Covid-19 is here and learning to live with it without the fear of being infected is one of the strategies in place, maybe the easiest one as of now. That said, Freezevacx has developed vaccine freezers to store and transport temperature sensitive vaccines and health aids by aircrafts during air travel. Freezevacx as the brand name implies objectify a device that helps with the storage and transportation of temperature sensitive vaccines in airplanes at ultra-low temperature of between -40ºC and -78,5°C. While discussing the build, use and specification of the newly invented airplane vaccine freezer, Alex Sahni, the founder of Freezevacx and Virus Guard; a company that has been busy with research and development of the Freezevacx freezer, stress that “the vaccine storage was designed for Airbus and Boeing. In his word, Freezevacx has made history by designing the world’s first ultra-low freezer for airport transportation. The three dimensional thermal insulation device will ensure fast and stable freezer, easy mobility, absolute reliability, user friendliness and flexible sample storage”. The freezer is in fact engineered for cold chain logistics for the transport of vaccines and pharmaceuticals. It works with a compressor freezing system by a rechargeable batterie. This means that the freezer will not be needing external power source nor support to work in aircrafts. The icing on the cake here is that the freezer has around 12 hours power back up, to maintain stable temperature during transportation. This helps it to keep temperature stable in the case of power failure. From close observation, the freezer is not anything short of user friendly as it represents quality ergonomics. It is manufactured with CFRT, which is well known for its extraordinary characteristics. Its strength, high stiffness and high toughness is widely used in automotive, aerospace and military industries. CFRT is environment friendly and light weight, what makes the freezer easy to load. Alex Sahni further described the aircraft freezer as an invention that combines health security with inflight convenience. The product has attracted a lot of praises and acceptance since it was first introduced. In fact, the founder is in talks with major airlines for adoption and use. Reacting to the product, an online product reviewer has said that it is both creative and innovative, and has shown the extents to which human can go to create solutions to a threatening situation. It also demonstrate the willingness of the inventor to create safety against biological threats as coronavirus and create a personally extended win for humanity against similar infections while aboard. More information about Freezevacx can be sourced at https://www.freezevacx.com/ (Added: Mon Nov 23 2020 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• Herbion Naturals to Launch an All-New Range of Pet Supplements - Herbion Pets - Herbion Naturals, a fast-growing all-natural healthcare organization, is all set to launch an exclusive range of pet care supplements brand, Herbion Pets. After years of perfecting herbal supplements for adults and children, the company is venturing into new grounds with the sole purpose of the betterment of pets across the nation. At the moment, the company has launched four wholesome nutritional supplements for canines of all breeds.  These dog supplements come in an air-tight jar of 120 soft chews made with finesse in the USA., in cGMP certified state-of-the-art facilities, using Mother Nature's finest ingredients. This launch makes Herbion the one-stop-shop for healthcare products for both people and their beloved furry pets.  The exclusive range of Herbion Pets dog chews consist of the following supplements:  Multivitamin Chews  Digestive Support Chews  Joint Care Chews  Allergy + Immune Chews  Herbion Pets Multivitamin Chews with Hemp & Probiotics contain 300 million CFU probiotics per chew for a bolt of energy. The all-natural blend consists of Vitamin C, Zinc, Organic Hemp Oil, Manganese, and Flaxseed, which promote canine coat health and immunity. This dietary supplement also supports heart, digestion, and brain health and comes in a bacon flavor that tastes like a treat. Their Joint Care Chews contain a powerhouse of ingredients, such as Glucosamine, Methylsulfonylmethane, and Organic Turmeric Root Powder, for joint pain relief in canines. Moreover, these natural chicken-flavored yummy chews also improve mobility and support healthy joints. As part of the line extension, Herbion Pets also has Digestive Support Chews with Probiotics & Enzymes. Packed with daily digestive enzymes and a minimum of 2 billion CFU probiotics per chew, this supplement breaks down food into tiny pieces, eliminates indigestion, and reduces stomach discomfort. Amylase in this delicious chicken-flavored supplement promotes gut health and absorption of nutrients among canines. Lastly, Allergy + Immune Chews with Kelp, Vitamin C, and vegetable-flavored dog chews contain a blend of Colostrum and Organic Licorice that protect canines against allergy symptoms. The potent blend of wholesome ingredients relieves itchy skin, maintains skin and coat health, strengthens immunity, and provides allergy relief. To ensure the utmost well-being of canines, the complete range of Herbion Pets dog chews are corn-free, dairy-free, soy-free, free of artificial colors, and artificial ingredients. Made with wholesome formulations these supplements are suitable for small, medium, and large dogs of all breeds 12 weeks and above. These bite-sized chews come in an array of delectable flavors that make for a fuss-free way of giving pets their daily supplements.  The complete range of Herbion Pets is readily available at leading health food stores and online for immediate doorstep delivery. The company hopes these supplements will help improve the well-being of canines across the country. About Herbion Naturals  Herbion Naturals houses a wide array of health and wellness products, such as cough, sore throat, respiratory care, and immune-boosting supplements for the whole family. Located in Fort Mill, South Carolina, the company consists of ingenious experts that work diligently to improve the lives of human and pet across America.  For more information or any further query related to the products, please visit: Website: https://www.herbion.us/  Facebook: Herbion Naturals USA Instagram: Herbion.usa YouTube: Herbion USA (Added: Mon Nov 23 2020 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Herbion Naturals to Launch an All-New Range of Pet Supplements - Herbion Pets - Herbion Naturals, a fast-growing all-natural healthcare organization, is all set to launch an exclusive range of pet care supplements brand, Herbion Pets. After years of perfecting herbal supplements for adults and children, the company is venturing into new grounds with the sole purpose of the betterment of pets across the nation. At the moment, the company has launched four wholesome nutritional supplements for canines of all breeds.  These dog supplements come in an air-tight jar of 120 soft chews made with finesse in the USA., in cGMP certified state-of-the-art facilities, using Mother Nature's finest ingredients. This launch makes Herbion the one-stop-shop for healthcare products for both people and their beloved furry pets.  The exclusive range of Herbion Pets dog chews consist of the following supplements:  Multivitamin Chews  Digestive Support Chews  Joint Care Chews  Allergy + Immune Chews  Herbion Pets Multivitamin Chews with Hemp & Probiotics contain 300 million CFU probiotics per chew for a bolt of energy. The all-natural blend consists of Vitamin C, Zinc, Organic Hemp Oil, Manganese, and Flaxseed, which promote canine coat health and immunity. This dietary supplement also supports heart, digestion, and brain health and comes in a bacon flavor that tastes like a treat. Their Joint Care Chews contain a powerhouse of ingredients, such as Glucosamine, Methylsulfonylmethane, and Organic Turmeric Root Powder, for joint pain relief in canines. Moreover, these natural chicken-flavored yummy chews also improve mobility and support healthy joints. As part of the line extension, Herbion Pets also has Digestive Support Chews with Probiotics & Enzymes. Packed with daily digestive enzymes and a minimum of 2 billion CFU probiotics per chew, this supplement breaks down food into tiny pieces, eliminates indigestion, and reduces stomach discomfort. Amylase in this delicious chicken-flavored supplement promotes gut health and absorption of nutrients among canines. Lastly, Allergy + Immune Chews with Kelp, Vitamin C, and vegetable-flavored dog chews contain a blend of Colostrum and Organic Licorice that protect canines against allergy symptoms. The potent blend of wholesome ingredients relieves itchy skin, maintains skin and coat health, strengthens immunity, and provides allergy relief. To ensure the utmost well-being of canines, the complete range of Herbion Pets dog chews are corn-free, dairy-free, soy-free, free of artificial colors, and artificial ingredients. Made with wholesome formulations these supplements are suitable for small, medium, and large dogs of all breeds 12 weeks and above. These bite-sized chews come in an array of delectable flavors that make for a fuss-free way of giving pets their daily supplements.  The complete range of Herbion Pets is readily available at leading health food stores and online for immediate doorstep delivery. The company hopes these supplements will help improve the well-being of canines across the country. About Herbion Naturals  Herbion Naturals houses a wide array of health and wellness products, such as cough, sore throat, respiratory care, and immune-boosting supplements for the whole family. Located in Fort Mill, South Carolina, the company consists of ingenious experts that work diligently to improve the lives of human and pet across America.  For more information or any further query related to the products, please visit: Website: https://www.herbion.us/  Facebook: Herbion Naturals USA Instagram: Herbion.usa YouTube: Herbion USA (Added: Mon Nov 23 2020 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• Get the Right Drug Treatment Program For You - Freeing yourself from drug addiction is hard. But you need not fight for your mental and physical independence alone. You can take advantage of the many professionals and multitude of Resources to get you through it.
  
  Recovery from Addiction is best done with the help of professionals in rehab centers. Once you have joined such a center, you will come under the care of people who are not there to judge you or second guess any decisions you may have made. There sole purpose is to help you get healthy again.
  
  Drug addiction is an illness, according to the American Medical Association. That means it can be treated and the persons who suffer from it led into recovery. No one decides to become a drug addict on a whim. Addiction always occurs gradually and without intention on the part of the victim.
  
  You may have gotten into drugs to help cope with some life trauma. It is also possible to get hooked after a whimsical experimentation with drugs. This happens more often than people think. You may have decided to do drugs at a party without any thought of the consequences; only to discover later on how addictive they can be.
  
  No matter your road to addiction, the important thing is to find a way off of it. The first step is admitting that you have a problem. The second step, often the hardest, is to seek help. Although you may have the love and support of your family and friends, you will need an intervention by trained and qualified professionals.
  
  Weaning you off your chemical dependency is the first stage of addiction recovery. This is a physically painful stage, but it can be eased by the right support. You will need to rebalance your body’s chemistry, which will require a diet that contains different kinds of vitamins and nutrients. You will also need to go through counselling. The point of these sessions is to get to the root of what drive you to take drugs in the first place. This can often help you deal with the more fundamental problems in your life.
  
  Going through counselling will also help reveal your triggers, which are the things that push you to use drugs. Once you know them, you can avoid and resist them.
  
  Unfortunately, there is no cure for drug addiction. However, you need not relapse into using, and you can build a strong network of support that will help you stay clean and sober. Getting the initial treatment you need will help you live a drug-free life. It will also help you build a new life—one that is fulfilling and that offers the kind of promise that can help you stay clean.
  
  You need not give up your job and family to go through recovery. Modern drug treatment programs are much more flexible than in times past. They offer a combination of inpatient and outpatient services that will allow you to deal with your addiction in a discrete and effective way. (Added: Sun Nov 22 2020 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Thommen Medical - the dedicated dental implant experts - The Swiss manufacturer Since 1975 the Swiss manufacturer Thommen Medical produces dental implant systems of outstanding high quality and precision. In 1996 the company introduced cylindrical implants and continues to this day in a product development based on latest scientific findings. The standard of Thommen Medical is to offer the best dental implant system for each patient. This is possible through close cooperation with leading international dentists and academic institutions. From the headquarters in Grenchen, Switzerland, the company manages a worldwide distribution with partners in Europe, Asia and the Middle East. Swiss implantology The dental implantology developped within the swiss industry is famous for its high precision and innovation. Tailored to the treatment concepts of leading clinicians, the Thommen Medical Implant Systems is based on a proven design that ensures safety and reliability. The product range with its highly reliable and aesthetic restorations is based on the Thommen Medical implant-abutment connection. It consists of a stabilizing ring and hexagon socket, small and high-strength abutment screws and a clever design of the abutment screw that offers protection against mechanical overload. Clinical longevity and high-class aesthetics are the results of this design. There are much more products and solutions Thommen Medical offers such as a MONO torque ratchet, the VECTOdrill, a guided surgery, Cad Cam restorations, mini dental implants and a digital workflow dentistry. All in common is their impressive precision for maximum safety, driven by science not trends. Patient's benefit With implant placements and restorations from Thommen Medical, patients experience an improved quality of life with regards to function and aesthetic which lasts a lifetime. Tooth replacements or dental implants affect the overall well-being. One can speak and chew better; a beautiful smile or laugh without any restrictions creates more confidence. Wether single or multiple tooth dental implants - with the superior product quality of Thommen Medical, the patient can rely on safety and user-friendliness. Thommen Medical implants are highly reliable and have an excellent success rate. For further information and precise product line presentations go visit the website or get in contact via phone or e-mail. Thommen Medical AG Mr. Pascal Eberhard Neckarsulmstrasse 28 CH - 2540 Grenchen Switzerland https://www.thommenmedical.com/en/dental-professionals (Added: Sat Nov 21 2020 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Thommen Medical - the dedicated dental implant experts - The Swiss manufacturer Since 1975 the Swiss manufacturer Thommen Medical produces dental implant systems of outstanding high quality and precision. In 1996 the company introduced cylindrical implants and continues to this day in a product development based on latest scientific findings. The standard of Thommen Medical is to offer the best dental implant system for each patient. This is possible through close cooperation with leading international dentists and academic institutions. From the headquarters in Grenchen, Switzerland, the company manages a worldwide distribution with partners in Europe, Asia and the Middle East. Swiss implantology The dental implantology developped within the swiss industry is famous for its high precision and innovation. Tailored to the treatment concepts of leading clinicians, the Thommen Medical Implant Systems is based on a proven design that ensures safety and reliability. The product range with its highly reliable and aesthetic restorations is based on the Thommen Medical implant-abutment connection. It consists of a stabilizing ring and hexagon socket, small and high-strength abutment screws and a clever design of the abutment screw that offers protection against mechanical overload. Clinical longevity and high-class aesthetics are the results of this design. There are much more products and solutions Thommen Medical offers such as a MONO torque ratchet, the VECTOdrill, a guided surgery, Cad Cam restorations, mini dental implants and a digital workflow dentistry. All in common is their impressive precision for maximum safety, driven by science not trends. Patient's benefit With implant placements and restorations from Thommen Medical, patients experience an improved quality of life with regards to function and aesthetic which lasts a lifetime. Tooth replacements or dental implants affect the overall well-being. One can speak and chew better; a beautiful smile or laugh without any restrictions creates more confidence. Wether single or multiple tooth dental implants - with the superior product quality of Thommen Medical, the patient can rely on safety and user-friendliness. Thommen Medical implants are highly reliable and have an excellent success rate. For further information and precise product line presentations go visit the website or get in contact via phone or e-mail. Thommen Medical AG Mr. Pascal Eberhard Neckarsulmstrasse 28 CH - 2540 Grenchen Switzerland https://www.thommenmedical.com/en/dental-professionals (Added: Sat Nov 21 2020 Hits: 7 Rating: 0.00 Votes: 0) Rate It

• Thommen Medical - the dedicated dental implant experts - The Swiss manufacturer Since 1975 the Swiss manufacturer Thommen Medical produces dental implant systems of outstanding high quality and precision. In 1996 the company introduced cylindrical implants and continues to this day in a product development based on latest scientific findings. The standard of Thommen Medical is to offer the best dental implant system for each patient. This is possible through close cooperation with leading international dentists and academic institutions. From the headquarters in Grenchen, Switzerland, the company manages a worldwide distribution with partners in Europe, Asia and the Middle East. Swiss implantology The dental implantology developped within the swiss industry is famous for its high precision and innovation. Tailored to the treatment concepts of leading clinicians, the Thommen Medical Implant Systems is based on a proven design that ensures safety and reliability. The product range with its highly reliable and aesthetic restorations is based on the Thommen Medical implant-abutment connection. It consists of a stabilizing ring and hexagon socket, small and high-strength abutment screws and a clever design of the abutment screw that offers protection against mechanical overload. Clinical longevity and high-class aesthetics are the results of this design. There are much more products and solutions Thommen Medical offers such as a MONO torque ratchet, the VECTOdrill, a guided surgery, Cad Cam restorations, mini dental implants and a digital workflow dentistry. All in common is their impressive precision for maximum safety, driven by science not trends. Patient's benefit With implant placements and restorations from Thommen Medical, patients experience an improved quality of life with regards to function and aesthetic which lasts a lifetime. Tooth replacements or dental implants affect the overall well-being. One can speak and chew better; a beautiful smile or laugh without any restrictions creates more confidence. Wether single or multiple tooth dental implants - with the superior product quality of Thommen Medical, the patient can rely on safety and user-friendliness. Thommen Medical implants are highly reliable and have an excellent success rate. For further information and precise product line presentations go visit the website or get in contact via phone or e-mail. Thommen Medical AG Mr. Pascal Eberhard Neckarsulmstrasse 28 CH - 2540 Grenchen Switzerland https://www.thommenmedical.com/en/dental-professionals (Added: Sat Nov 21 2020 Hits: 11 Rating: 0.00 Votes: 0) Rate It

• You are on the Right Place for every Kind of Lymphatic Therapy Services In San Diego - One of the most widely recognized fat disorder is Lipedema (agonizing fat condition) is an ongoing infection that happens generally in females. It is described by two-sided, even greasy tissue overabundance, for the most part in the hip district, upper and lower leg regions and joined with a propensity for leg growing that compounds with standing. In male patients lipedema is amazingly uncommon. Lipedema is regularly misdiagnosed as reciprocal lower limit lymphedema or as basic stoutness. We are trying our best to eliminate fat issues from your body through our lymphatic massage therapy lymphedema in San Diego. In case you're in danger of lymphedema — for example, in the event that you've as of late had disease medical procedure including your lymph hubs —our care experts and physician will analyze lymphedema dependent on your signs and indications. In the event that the reason for your lymphedema isn't as self-evident, our therapists will arrange imaging tests to get a glance at your lymph framework. Tests may include X-ray filter (utilizing an attractive field and radio waves, a MRI produces 3-D, high-goal pictures), CT Scan (this X-beam strategy produces nitty gritty, cross-sectional pictures of your body's structures) and it sweeps can uncover blockages in the lymphatic framework. Doppler ultrasound (this variety of the traditional ultrasound sees blood stream and weight by bobbing high-recurrence sound waves off red platelets. Ultrasound can help discover hindrances and radionuclide imaging of your lymphatic framework. During this test you're infused with a radioactive color and afterward checked by a machine. we create modified lymphedema massage therapy in San Diego that intends to help individuals with lymphedema ease torment, diminish expanding, bring down the danger of disease and learn self-administration strategies. Lymphedema is the assortment of liquids in a piece of the body that can cause growing weight and torment. To help lighten expanding and lessen uneasiness, the advisors create care plans for complete decongestive lymphedema treatment that includes exercise based recuperation is the main line of treatment for lymphedema. In the event that these medicines don't help, surgeries are accessible to help you and ease the inconvenience related with lymphedema. So best lymphedema in San Diego provide you a solution for these problems and manual lymph waste has come to be perceived for its significant advantages to oncology customers following a medical procedure and later during their continuous recuperation period. MLD lessens edema, enables control to torment, mitigates clogging brought about by torment prescriptions, gives general unwinding, diminishes pressure and improves rest. Because of the multifaceted nature of treatment and care for oncology patients, our massage specialists organize treatment according to costumers need. Lipedema patients frequently discover swimming to be an extraordinary low-sway movement, as more lively exercises like running are regularly excessively agonizing. Our team suggests that exercise additionally helps the lymphatic liquid travel through the lymph framework all the more adequately, and is incredible for forestalling different issues, for example, cardiovascular issues. Ricocheting on a trampoline/rebounder, yoga, pilates, moderate extending, and strolling are all development that underpins lymphatic stream. (Added: Sat Nov 21 2020 Hits: 13 Rating: 0.00 Votes: 0) Rate It

• Best Gupt Rog Doctor In Delhi - Dr. RAINA'S SAFE HANDS CLINIC are The Best Leading Sexologists Doctors Clinic in Delhi with moreover 20 years of experience in the Medical Industry. (Added: Fri Nov 20 2020 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• Best Gupt Rog Doctor In Delhi - Dr. RAINA'S SAFE HANDS CLINIC are The Best Leading Sexologists Doctors Clinic in Delhi with moreover 20 years of experience in the Medical Industry. (Added: Fri Nov 20 2020 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Ayushakti - Ayushakti is one of the leading and most trusted ayurvedic health centres around the world. Co-founded by Ayurveda expert Dr. Smita Pankaj Naram in 1987, Ayushakti has played an integral role in promoting Ayurveda across the globe in including Asia, the U.S.A., Australia, New Zealand, Europe and UK. With a mission to create Long lasting transformation in community health Ayushakti has successfully helped people from 108 countries suffering from Asthma, allergies, Arthritis, Diabetes, Psoriasis, stress & Depression, Chronic Fatigue Syndrome, Back pain, Fibromyalgia, Obesity, Infertility, female health problems, High Blood Pressure, Skin & Hair Problems, Epilepsy, Autism, IBS, children health problems, and many other chronic health challenges through their revolutionary medical practices. Today, Ayushakti helps more 75000 people every year around the world. Currently, the company operates in nine countries serving over one million customers, offering a wide array of modern-day Ayurvedic Panchkarma (detox) treatments and medicines. Ayushakti has 29 highly trained expert Ayurvedic doctors (Vaidyas) for its services and a team of 150 western medical doctors, naturopaths, and chiropractors practicing in the U.S.A., Europe, Australia, New Zealand, and Russia who also travel across the world for personal health consultations for the clients, conducting workshops and training courses on Pulse reading and Ayurveda. Their unique offerings include Ancient pulse reading, Proven effective herbal remedies, Ancient authentic Detoxification Panchkarma treatments, Customized Diet plans, and Marma (Ayurvedic pressure point techniques). This combination of treatment ensures Vibrant health and long-lasting relief from chronic health challenges. Ayushakti serves clients across the world with their efficient clinics, of which 14 are in Mumbai. In addition to this, they have health resorts, two in India (Mumbai and Goa) and one in Germany. They also administer their services through their alliance clinics across the world. Certified by GMP FDA, Maharashtra, India, ISO 9001: 2015, Ayushakti has also notified more than 65 of its herbal products to the German Ministry of health, which makes it one of the few Ayurvedic companies to market and sell its products in Germany. They have been exporting herbal remedies to USA, Europe, Australia, New Zealand, Russia for the past 32 years. (Added: Fri Nov 20 2020 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Ayushakti - Ayushakti is one of the leading and most trusted ayurvedic health centres around the world. Co-founded by Ayurveda expert Dr. Smita Pankaj Naram in 1987, Ayushakti has played an integral role in promoting Ayurveda across the globe in including Asia, the U.S.A., Australia, New Zealand, Europe and UK. With a mission to create Long lasting transformation in community health Ayushakti has successfully helped people from 108 countries suffering from Asthma, allergies, Arthritis, Diabetes, Psoriasis, stress & Depression, Chronic Fatigue Syndrome, Back pain, Fibromyalgia, Obesity, Infertility, female health problems, High Blood Pressure, Skin & Hair Problems, Epilepsy, Autism, IBS, children health problems, and many other chronic health challenges through their revolutionary medical practices. Today, Ayushakti helps more 75000 people every year around the world. Currently, the company operates in nine countries serving over one million customers, offering a wide array of modern-day Ayurvedic Panchkarma (detox) treatments and medicines. Ayushakti has 29 highly trained expert Ayurvedic doctors (Vaidyas) for its services and a team of 150 western medical doctors, naturopaths, and chiropractors practicing in the U.S.A., Europe, Australia, New Zealand, and Russia who also travel across the world for personal health consultations for the clients, conducting workshops and training courses on Pulse reading and Ayurveda. Their unique offerings include Ancient pulse reading, Proven effective herbal remedies, Ancient authentic Detoxification Panchkarma treatments, Customized Diet plans, and Marma (Ayurvedic pressure point techniques). This combination of treatment ensures Vibrant health and long-lasting relief from chronic health challenges. Ayushakti serves clients across the world with their efficient clinics, of which 14 are in Mumbai. In addition to this, they have health resorts, two in India (Mumbai and Goa) and one in Germany. They also administer their services through their alliance clinics across the world. Certified by GMP FDA, Maharashtra, India, ISO 9001: 2015, Ayushakti has also notified more than 65 of its herbal products to the German Ministry of health, which makes it one of the few Ayurvedic companies to market and sell its products in Germany. They have been exporting herbal remedies to USA, Europe, Australia, New Zealand, Russia for the past 32 years. (Added: Fri Nov 20 2020 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Ayushakti - Ayushakti is one of the leading and most trusted ayurvedic health centres around the world. Co-founded by Ayurveda expert Dr. Smita Pankaj Naram in 1987, Ayushakti has played an integral role in promoting Ayurveda across the globe in including Asia, the U.S.A., Australia, New Zealand, Europe and UK. With a mission to create Long lasting transformation in community health Ayushakti has successfully helped people from 108 countries suffering from Asthma, allergies, Arthritis, Diabetes, Psoriasis, stress & Depression, Chronic Fatigue Syndrome, Back pain, Fibromyalgia, Obesity, Infertility, female health problems, High Blood Pressure, Skin & Hair Problems, Epilepsy, Autism, IBS, children health problems, and many other chronic health challenges through their revolutionary medical practices. Today, Ayushakti helps more 75000 people every year around the world. Currently, the company operates in nine countries serving over one million customers, offering a wide array of modern-day Ayurvedic Panchkarma (detox) treatments and medicines. Ayushakti has 29 highly trained expert Ayurvedic doctors (Vaidyas) for its services and a team of 150 western medical doctors, naturopaths, and chiropractors practicing in the U.S.A., Europe, Australia, New Zealand, and Russia who also travel across the world for personal health consultations for the clients, conducting workshops and training courses on Pulse reading and Ayurveda. Their unique offerings include Ancient pulse reading, Proven effective herbal remedies, Ancient authentic Detoxification Panchkarma treatments, Customized Diet plans, and Marma (Ayurvedic pressure point techniques). This combination of treatment ensures Vibrant health and long-lasting relief from chronic health challenges. Ayushakti serves clients across the world with their efficient clinics, of which 14 are in Mumbai. In addition to this, they have health resorts, two in India (Mumbai and Goa) and one in Germany. They also administer their services through their alliance clinics across the world. Certified by GMP FDA, Maharashtra, India, ISO 9001: 2015, Ayushakti has also notified more than 65 of its herbal products to the German Ministry of health, which makes it one of the few Ayurvedic companies to market and sell its products in Germany. They have been exporting herbal remedies to USA, Europe, Australia, New Zealand, Russia for the past 32 years. (Added: Fri Nov 20 2020 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Ayushakti - Ayushakti is one of the leading and most trusted ayurvedic health centres around the world. Co-founded by Ayurveda expert Dr. Smita Pankaj Naram in 1987, Ayushakti has played an integral role in promoting Ayurveda across the globe in including Asia, the U.S.A., Australia, New Zealand, Europe and UK. With a mission to create Long lasting transformation in community health Ayushakti has successfully helped people from 108 countries suffering from Asthma, allergies, Arthritis, Diabetes, Psoriasis, stress & Depression, Chronic Fatigue Syndrome, Back pain, Fibromyalgia, Obesity, Infertility, female health problems, High Blood Pressure, Skin & Hair Problems, Epilepsy, Autism, IBS, children health problems, and many other chronic health challenges through their revolutionary medical practices. Today, Ayushakti helps more 75000 people every year around the world. Currently, the company operates in nine countries serving over one million customers, offering a wide array of modern-day Ayurvedic Panchkarma (detox) treatments and medicines. Ayushakti has 29 highly trained expert Ayurvedic doctors (Vaidyas) for its services and a team of 150 western medical doctors, naturopaths, and chiropractors practicing in the U.S.A., Europe, Australia, New Zealand, and Russia who also travel across the world for personal health consultations for the clients, conducting workshops and training courses on Pulse reading and Ayurveda. Their unique offerings include Ancient pulse reading, Proven effective herbal remedies, Ancient authentic Detoxification Panchkarma treatments, Customized Diet plans, and Marma (Ayurvedic pressure point techniques). This combination of treatment ensures Vibrant health and long-lasting relief from chronic health challenges. Ayushakti serves clients across the world with their efficient clinics, of which 14 are in Mumbai. In addition to this, they have health resorts, two in India (Mumbai and Goa) and one in Germany. They also administer their services through their alliance clinics across the world. Certified by GMP FDA, Maharashtra, India, ISO 9001: 2015, Ayushakti has also notified more than 65 of its herbal products to the German Ministry of health, which makes it one of the few Ayurvedic companies to market and sell its products in Germany. They have been exporting herbal remedies to USA, Europe, Australia, New Zealand, Russia for the past 32 years. (Added: Fri Nov 20 2020 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Ayushakti - Ayushakti is one of the leading and most trusted ayurvedic health centres around the world. Co-founded by Ayurveda expert Dr. Smita Pankaj Naram in 1987, Ayushakti has played an integral role in promoting Ayurveda across the globe in including Asia, the U.S.A., Australia, New Zealand, Europe and UK. With a mission to create Long lasting transformation in community health Ayushakti has successfully helped people from 108 countries suffering from Asthma, allergies, Arthritis, Diabetes, Psoriasis, stress & Depression, Chronic Fatigue Syndrome, Back pain, Fibromyalgia, Obesity, Infertility, female health problems, High Blood Pressure, Skin & Hair Problems, Epilepsy, Autism, IBS, children health problems, and many other chronic health challenges through their revolutionary medical practices. Today, Ayushakti helps more 75000 people every year around the world. Currently, the company operates in nine countries serving over one million customers, offering a wide array of modern-day Ayurvedic Panchkarma (detox) treatments and medicines. Ayushakti has 29 highly trained expert Ayurvedic doctors (Vaidyas) for its services and a team of 150 western medical doctors, naturopaths, and chiropractors practicing in the U.S.A., Europe, Australia, New Zealand, and Russia who also travel across the world for personal health consultations for the clients, conducting workshops and training courses on Pulse reading and Ayurveda. Their unique offerings include Ancient pulse reading, Proven effective herbal remedies, Ancient authentic Detoxification Panchkarma treatments, Customized Diet plans, and Marma (Ayurvedic pressure point techniques). This combination of treatment ensures Vibrant health and long-lasting relief from chronic health challenges. Ayushakti serves clients across the world with their efficient clinics, of which 14 are in Mumbai. In addition to this, they have health resorts, two in India (Mumbai and Goa) and one in Germany. They also administer their services through their alliance clinics across the world. Certified by GMP FDA, Maharashtra, India, ISO 9001: 2015, Ayushakti has also notified more than 65 of its herbal products to the German Ministry of health, which makes it one of the few Ayurvedic companies to market and sell its products in Germany. They have been exporting herbal remedies to USA, Europe, Australia, New Zealand, Russia for the past 32 years. (Added: Fri Nov 20 2020 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• Your Divine Timing is Calling You! - Become Instructor of Awakening Family Bonds Basic Course with Romshri November 28-29th, 2020 Mode: Online Pre-Requisite: Basic Course of Awakening Family Bonds and ThetaHealing Basic DNA This course will empower and train you to become Instructor of Awakening Family Bonds Basic course and start teaching it. Why You should become an Instructor with Awakening Love Academy? The instructors of Academy are the integral part of our world community. As an instructor you empower others and yourself too by learning and teaching others continuously. This not only empowers you spiritually but also provide you great scholarships, benefits, support, social media promotions and professional support to be able to teach your courses by Awakening Love Academy. If teaching is your calling, we are here for you! Everyday timing: 10 am to 12:30 pm. Break. 3:30 pm to 5 pm (Timings can be flexible and subject to change) Scholarships: Register & claim the scholarship by paying only 8,000 INR. Pay rest of fee anytime before the workshop. Apply & query at info@awakeninglove.co Summary of previous course with participants testimonials: https://mailchi.mp/392e06fd1491/summary-awakening-family-bonds-with-romshri Team Awakening Love Academy www.awakeninglove.co (Added: Fri Nov 20 2020 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Balance Physical Therapy expands beyond Salinas and Monterey facilities by opening in Prunedale - A native of the Salinas Valley, Dr. John Farahmand founded Balance Physical Therapy and Human Performance Center in 2002, vowing to build the most patient-focused, result-oriented rehabilitation facility in Monterey County. Monterey, CA, November 19, 2020 - A native of the Salinas Valley, Dr. John Farahmand founded Balance Physical Therapy and Human Performance Center in 2002, vowing to build the most patient-focused, result-oriented rehabilitation facility in Monterey County. Using innovative exercise interventions, advanced rehabilitation techniques, and the latest in research and science, Dr. Farahmand and his team quickly expanded the practice, with offices in Monterey (2260 N. Fremont St.) and Salinas (143 John St.). Based on its reputation as a result-oriented rehabilitation facility committed to helping patients return to an active lifestyle, BPT has now expanded further, opening a third location (January 2021) in Prunedale at 17760 Moro Road, Suite #120 The new facility will serve Prunedale, Castroville, Watsonville, Gilroy, San Benito County and South Monterey County. “We are excited to become an integrated part of these communities,” said Dr. Farahmand. “We have a team of highly trained physical therapists and committed to helping our patients live a happy, healthy, and pain-free life” To better serve and connect with the region, BPT will join both North County Chamber of Commerce and Pajaro Chamber of Commerce. There is a planned joint virtual ribbon cutting ceremony on Thursday, January 28th at 5:00 p.m. with those chambers, along with Salinas Valley Chamber of Commerce, with details pending. For more information, visit www.balancept.com. Contact: Marci Bracco Cain The Buzz PR LLC Salinas, CA (831) 747-7455 http://www.balancept.com (Added: Fri Nov 20 2020 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• Virusjet Announces Unmanned Disinfection Device - The world has been sick since the pandemic outbreak in February 2020, and so it is in dire need of a messiah from the hands of the life-wiping Covid-19 virus. This understood, health and environment inventors alongside concerned entities who fancy the protection of lives against infections have prioritized human safety amidst the global disaster. People, companies and public establishments like the World Health Organization (WHO) have conducted and reviewed various vaccine researches as well as suggested precaution ideas against the outbreak. Virusjet has also since joined in the league of private entities that are trying to find possible solutions to the situation especially via disinfection. Virusjet has shown relentlessness in its inventiveness and innovative desires to attain groundbreaking victory against the recent infamous pandemic outbreak whose negative impacts have been felt hugely around the world. Since a cure is yet unknown or at least legally ratified by World Health Organization for public use, disinfection has been touted as one of the best precautionary move against easy spread of the virus. In lieu of the said facts, Virusjet has produced sets of tremendous top quality disinfectants to keep surfaces clean and avoid the spread as well as cross contamination of coronavirus and related pathogens via surfaces, private ambience and shared public spaces. The motive of the organization has always been to produce a wide covering pathogen killing disinfection material which will reach and be useful for everyone regardless of location, need and social status. That way, the first stream of products from the organization comes in varieties for schools and hospitals, industries, aviation use, surfaces in homes and public spaces. Virusjet delivers top disinfection fluid that coats all surfaces without making them wet. On top of this, each products under this umbrella ensures real time disinfection on surfaces and lasts as much as ten days after the first spray. Also, each of the products have their uniqueness especially in terms of build and use format, all to attain disinfection efficiency. In further pursuit of the mission of the organization to end infection spread and cross contamination via disinfection especially in air travel sector and aviation industry, it keeps working on designing products for uniform distribution of disinfectant particles on focused surface. To this end, it has created a new product that adds convenience to the search for human safety against pathogens. As the manufacturer of ULV disinfection innovation, it recently unveiled the “unmanned disinfection device”. This device simply sits on a table or similar surface while it is set to the capacity of the room under disinfection. The start button is pressed and the device will take only 15 seconds to begin disinfection until the ambience is thoroughly and fully disinfected. The device is a creation of class and inventiveness in one body. It is revered as the most compact and powerful diffusing machine that is designed with powerful turbine motor which propels it to deliver dry mist and covers invariably between 10 and 1000 cubic meter including hard to reach surfaces. The deep spraying exhibited by this device is engineered with unique diffusion principle which does not in any way cause wetness on target surfaces. The highly hygrometric device works without condensation, oozing out droplets of 4 to 5 microns at every spray. The device is useful to spray disinfectants ranging from fungicides to biocides, insecticides and hydrogen peroxide among others. It has a maximum service run time of 60 minutes pluggable to a 220V/110V/ special motor for Airbus and Boeing Aircrafts. With a global warranty of 24 months and CE certification from TUV Austria, you can be certain of spending your cash on top quality product that will give you desirable disinfection results in maximum convenience. Aircrafts disinfection has become categorically easy with a device that works unmanned on aircraft power and disinfects narrow-body Airbus and Boeing aircraft within 20 mins. Beyond its scope of use in the aircrafts and aviation industry, Virusjet’s “unmanned disinfection device” can be used to cover inanimate environment in the hospital, average hotel and care room in less than two minutes, production centers cleaning and in fact, rooms in schools and university. The device can therefore be called a multipurpose build of disinfection ease that doesn’t necessarily need human support. It’s simply an undeniable class of a product in the new world of disinfection. (Added: Thu Nov 19 2020 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Virusjet Announces Unmanned Disinfection Device - The world has been sick since the pandemic outbreak in February 2020, and so it is in dire need of a messiah from the hands of the life-wiping Covid-19 virus. This understood, health and environment inventors alongside concerned entities who fancy the protection of lives against infections have prioritized human safety amidst the global disaster. People, companies and public establishments like the World Health Organization (WHO) have conducted and reviewed various vaccine researches as well as suggested precaution ideas against the outbreak. Virusjet has also since joined in the league of private entities that are trying to find possible solutions to the situation especially via disinfection. Virusjet has shown relentlessness in its inventiveness and innovative desires to attain groundbreaking victory against the recent infamous pandemic outbreak whose negative impacts have been felt hugely around the world. Since a cure is yet unknown or at least legally ratified by World Health Organization for public use, disinfection has been touted as one of the best precautionary move against easy spread of the virus. In lieu of the said facts, Virusjet has produced sets of tremendous top quality disinfectants to keep surfaces clean and avoid the spread as well as cross contamination of coronavirus and related pathogens via surfaces, private ambience and shared public spaces. The motive of the organization has always been to produce a wide covering pathogen killing disinfection material which will reach and be useful for everyone regardless of location, need and social status. That way, the first stream of products from the organization comes in varieties for schools and hospitals, industries, aviation use, surfaces in homes and public spaces. Virusjet delivers top disinfection fluid that coats all surfaces without making them wet. On top of this, each products under this umbrella ensures real time disinfection on surfaces and lasts as much as ten days after the first spray. Also, each of the products have their uniqueness especially in terms of build and use format, all to attain disinfection efficiency. In further pursuit of the mission of the organization to end infection spread and cross contamination via disinfection especially in air travel sector and aviation industry, it keeps working on designing products for uniform distribution of disinfectant particles on focused surface. To this end, it has created a new product that adds convenience to the search for human safety against pathogens. As the manufacturer of ULV disinfection innovation, it recently unveiled the “unmanned disinfection device”. This device simply sits on a table or similar surface while it is set to the capacity of the room under disinfection. The start button is pressed and the device will take only 15 seconds to begin disinfection until the ambience is thoroughly and fully disinfected. The device is a creation of class and inventiveness in one body. It is revered as the most compact and powerful diffusing machine that is designed with powerful turbine motor which propels it to deliver dry mist and covers invariably between 10 and 1000 cubic meter including hard to reach surfaces. The deep spraying exhibited by this device is engineered with unique diffusion principle which does not in any way cause wetness on target surfaces. The highly hygrometric device works without condensation, oozing out droplets of 4 to 5 microns at every spray. The device is useful to spray disinfectants ranging from fungicides to biocides, insecticides and hydrogen peroxide among others. It has a maximum service run time of 60 minutes pluggable to a 220V/110V/ special motor for Airbus and Boeing Aircrafts. With a global warranty of 24 months and CE certification from TUV Austria, you can be certain of spending your cash on top quality product that will give you desirable disinfection results in maximum convenience. Aircrafts disinfection has become categorically easy with a device that works unmanned on aircraft power and disinfects narrow-body Airbus and Boeing aircraft within 20 mins. Beyond its scope of use in the aircrafts and aviation industry, Virusjet’s “unmanned disinfection device” can be used to cover inanimate environment in the hospital, average hotel and care room in less than two minutes, production centers cleaning and in fact, rooms in schools and university. The device can therefore be called a multipurpose build of disinfection ease that doesn’t necessarily need human support. It’s simply an undeniable class of a product in the new world of disinfection. (Added: Thu Nov 19 2020 Hits: 11 Rating: 0.00 Votes: 0) Rate It

• What Are The Dangers Of Buying Counterfeit Batteries For Your Medical Devices - Medical devices are crucial in the provision of medical services as well as in monitoring patients. And it goes without saying that these devices should be of high quality -- and are powered by genuine battery packs. Unfortunately, the issue of counterfeit batteries is rampant in the field of medicine.
  
  In this article, we’re discussing the dangers of these fake batteries.
  
  Consequences of Counterfeit Batteries
  
  The use of a medical battery is especially helpful for portable devices. However, they also serve as a dependable backup for those that need a continuous power supply.
  
  When counterfeit batteries are used, the devices they supply power to will be rendered unsafe and unreliable for the patients involved. In the worst cases, it can be a matter of life-and-death situation -- especially when the device that needs to be used is a life-critical one such as ventilators. Fake batteries can also decrease the life of medical devices.
  
  Apart from the immediate consequences to the patient, these batteries can also affect the reputation of the healthcare facility and the device’s manufacturer. Take note that fake batteries use the logo or trademark of a manufacturing company; hence, when the device fails to perform its function, it is usually the operator and the device itself that get the blame first.
  
  To curb the use of counterfeit batteries, the government is also prompted to heighten their efforts in tracking down the suppliers of these rather hazardous batteries.
  
  Tips: Preventing Being a Victim of a Fake Medical Battery
  
  To help combat the issue of fake medical batteries, anyone who works in the healthcare field or is involved in taking care of a patient should know how to spot counterfeit ones.
  
  Research about the manufacturer. Manufacturers are aware of the prevalence of fake batteries in the market. As a countermeasure, they're equipping original ones with features that will separate them from fake ones -- including seam serial numbers, quality battery wraps and stickers.
  
  Beware of visible defects. If the battery has visible burn marks, scratches and rust spots, you have to avoid using it for your medical device. This is why it's important to thoroughly inspect the batteries you're buying or you've bought before inserting it to your medical gear and machines.
  
  Buy only from trusted suppliers. If you want to really prevent getting hold of fake batteries and avoid spending for such dangerous counterfeits, it's best to procure these items only from a credible vendor. Look into their license and certification -- and research if they're indeed allowed to sell batteries from recognised manufacturers.
  
  If you're looking for authentic, highly durable medical batteries and medical battery packs, get in touch with no other than the leading supplier of such commodities to the UK’s National Health Service. Euro Energy has been in the industry for more than four decades now, working only with top manufacturers in the healthcare industry. Their array of products include compatible medical batteries, original medical batteries and general-purpose cells. Contact them at +44(0) 116 234 0567 or at info@euroenergy.co.uk. Visit www.euroenergy.co.uk for more details. (Added: Thu Nov 19 2020 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Genomics Global Market – Forecast To 2027 - Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes, this also involves the study of interactions between genes and their surrounding environment. It provides significant information to solve biological problems through analysis of genomes using several technologies such as Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In-situ hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT) and others technologies. The genomic data generated by these technologies are helpful in designing personalized medicines, drug discovery, diagnosis, biomarker discovery and in therapy development. According to IQ4I analysis, the genomics global market is expected to grow at mid single digit CAGR from 2020 to 2027 to reach $31,835.9 million in 2027. The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic technologies in drug discovery & development and technological advancements. In addition, the outbreak of global pandemic COVID-19 has shown a sudden surge in demand for genomics-based techniques in the screening of the diseased population. Whereas, factors restraining the market growth are high cost of instruments and special research materials, analytical validity of the result, lack of standardization, complexity, lack of skilled professionals, stringent and time-consuming regulatory guidelines, data security and large data management issues are threats to market growth. The genomics global market is classified into product, application, end-user, and geography. Based on product type, the market is segmented into instruments, consumables, software & services and genomics services. Among the product type, consumables accounted for the largest revenue in 2020 and the market is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics services is fastest growing segment at a high single digit CAGR of from 2020 to 2027 due to increasing pharma companies focus towards the adoption of genetic technologies in the drug discovery & development, increased interest in the development of newer diagnostics, launch of new genomic services and also growing attention toward direct to consumer based genetic tests. In Genomics services, NGS services hold the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics global market is classified based on application into Diagnostics, Drug Discovery& Development, Plant Genomics and Others. Among applications, diagnostics segment accounted for the largest revenue in 2020 and is expected grow at a high single digit CAGR from 2020 to 2027, due to increased incidence of cancer, increased interest in early screening & prenatal screening of genetic diseases, decreasing test cost, the outbreak of various infectious diseases in recent years, reimbursement facility, and advancements in analytical tools. Among the diagnostics sub-segment market, the infectious diseases segment accounted for the largest revenue in 2020 and is expected grow at a mid single digit CAGR from 2020 to 2027. This is attributed to increased application of genomic technology based tests in the detection of pathogen, mainly in outbreak investigations due to its accurate detection. However, the non-infectious disease is fastest growing segment and is expected to grow at a high single digit CAGR from 2020 to 2027. This is attributed to increased application NGS based genetic tests for early screening of cancers & prenatal screening and rapid development of personalized medicine tests for the selection of patients for suitable treatments. The end-users of genomics market is segmented into Pharma & Biotech, Hospital & Clinical Laboratories, Contract Research Organization (CRO's) and others. Among the end-users, Hospital & Clinical Laboratories segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027 attributed to the increasing adoption of early cancer screening tests; increased interest towards NGS based prenatal screening, the outbreak of infectious diseases and reduced testing cost. The Contract Research Organization (CRO's) is expected to grow at a high single digit CAGR from 2020 to 2027 due to increased outsourcing for maximum utilization of genomic technologies in drug discovery process, the launch of new genomic services and increasing capabilities to offer end-to-end genomic services. The genomics global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (RoW). Among various geographies, the North America region dominated the genomics global market with the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. This is due to the increasing R&D expenditure, development and adoption of the latest genomic technologies, presence of major players, increasing use of genomics technologies in early screening, prenatal screening, personalized medicine, reduced testing cost, and crop improvement research and increased funding from private and government agencies. The Asia-Pacific region is the fastest-growing region at a double digit CAGR from 2020 to 2027. This is attributed to the presence of a large number of CROs, growing awareness in the adoption of genomics in early screening, prenatal screening, personalized medicine & crop improvement research, increased government funding towards genomics research & development of companion diagnostics and increased number of start-up & medical genetics companies to develop innovative genomic technologies. Some of the advancements in genomic technologies are the expansion of single-cell biology, advancements in data analysis, databases, integration of machine learning & deep learning, the evolution of third-generation sequencing technology, advancement in genome editing technologies and also emerging CRISPR screening and diagnostics. The advancement of NGS technologies has enabled studying normal biological processes and diseases at a single-cell resolution which helps to clearly understand gene expression, immune profiling and epigenetic mechanisms of single-cell further enhances the application of genomics. For instance, In September 2020, 10x Genomics company launched Chromium Single Cell Multiome ATAC + Gene Expression solution capable of simultaneously profiling the epigenome and transcriptome from the same single cell and also can use this information to precisely engineer more effective immunotherapies in the future. The emerging long-read sequencing (LRS) or third-generation sequencing technologies may provide solutions for improving the characterization of genetic variation and regions that are difficult to assess with the prevailing short-read sequencers (NGS technologies). CRISPR-Cas genome editing technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications and most useful in biomedical research. The speed, simplicity, and precision with which CRISPR-Cas9 technology enables genetic elements to be mutated, silenced, induced, or replaced have resulted in its widespread adoption by the global research community. Also, a plethora of successful CRISPR-Cas-based approaches to detect and diagnose various infectious and non-infectious diseases have been pioneered. Combination of genomics and AI will answer many unresolved questions and opens door for new discoveries. The overall aim is to use AI algorithms to analyze genomic data sets (e.g. associations between variants and molecular or physiological measures of health/disease), which could then provide new parameters for healthcare personalization, identify new disease biomarkers, and refine understanding of disease. Also, the integration of AI into novel genome editing technologies such as CRISPR-Cas provides precise location for DNA alteration and also insights about how to ensure that the repair process of the DNA strand is successful; helping in reducing potential mistakes during the entire process. For instance, Dante Labs is a genetic testing and data analysis company, integrated artificial intelligence (AI) tool to create personalized reports from whole genome sequencing data that leverages a person's medical information to identify the most relevant insights for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. The Genomics market is consolidated with the 6 top players occupying xx% of the market share and the remaining xx% of the market is occupied by other players and service providers. Companies are adopting various organic and inorganic strategies for market expansion. To gain more market share, companies are constantly focusing on developing innovative technologies and differentiated products. For instance, in July 2020, Myriad Genetics, Inc., launched proprietary AMPLIFY technology, to increases the performance of non-invasive prenatal screening (NIPS) tests. In August 2020, Illumina, Inc. launched a new NovaSeq6000 v1.5 Reagent Kits. The new kits bring data-rich applications—such as single-cell genomics, whole-genome sequencing, and liquid biopsy. Genomics is also gaining its importance in the development of precision medicine. NGS-based companion diagnostics paved a new pathway for the selection of candidates for targeted treatment. For instance, in September 2020, Thermo Fisher Scientific received premarket approval from the FDA for an NGS-Based companion diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer. It is the first and only FDA-approved test for targeted treatment for RET fusion-positive NSCLC. Genomic services are gaining importance day by day, so the companies are engaged in the lunch of new genomic services for the maximum utilization of genomics technologies in various applications like drug discovery, diagnosis, crop improvement, etc. For instance, in the COVID -19 pandemic, Eurofins Genomics launched SARS-CoV-2 Full-length Genome Sequencing services aimed at supporting researchers globally in their fight against the COVID-19 pandemic. The service enables accurate identification, strain typing, surveillance of mutational drift and phylogenetic distances between locally and regionally different viral isolate genome sequences. Additionally, several personal genomics startup companies that offer direct to consumer genetic testing are gaining more attention by launching new services. For instance, in February 2020, Nebula Genomics launched a consumer product (30x Whole Genome Sequencing DNA Test) that will offer users whole genome sequencing for $299, Nebula Genomics' whole-genome sequencing analyzes more than 6 billion genetic variants. With this launch, Nebula Genomics also expands its services to 188 countries. These launches mark a dramatic shift in consumer-initiated genetic testing services. It is also estimated that the integration of genomics in the drug discovery process will reduce up to 35% cost and 15% time and with introduction of improved genomics technologies, the savings will be even greater. Pharmaceutical companies have realized the importance of genomics in the drug development process and are incorporating genomics approaches in their drug development process by entering into a strategic collaboration with genomic companies. For instance, in January 2020, Eisai Co., Ltd partnered with Personal Genome Diagnostics to develop a comprehensive liquid biopsy biomarker discovery solution for oncology. Similarly, in February 2020, Atrin Pharmaceuticals collaborated with the Predictive Technology Group to apply genomic analysis to optimize patient selection for Atrin’s upcoming ATRN-119 clinical trial. Predictive is using a genomic database analytics approach to help with patient selection, to increase efficiencies and quality of clinical trials. In developing countries, CROs are showing interest to incorporate genomic services in order to increase service capabilities. For instance, in January 2020, A2 Healthcare Corp. that engages in CRO business in Japan a subsidiary of ITOCHU Corporation entered a capital and business alliance, with iLAC, inc., to launch a whole-genome analysis business. A2 Healthcare will start providing Japan's first pharmaceutical development service that includes whole-genome analysis in collaboration with iLAC. Genomics research was fueled initially by government and nonprofit funding sources, later augmented by private research and development (R&D) funding. According to IQ4I research, during the period 2019-20, approximately $xx million was invested by various companies and government agencies. The funding was received for potential genomics applications, namely disease research, diagnosis, Genetic Risk Assessment, Biomarker Discovery, Crop Improvement, Capacity Expansion, Drug Discovery, Personalized Treatment, AI-based Genomics Platform and Others. The disease research application received the highest funding of $509.4 million from 2019 to 2020 due to increasing investment from the government agencies in the genome sequencing projects and also, development of new genomic tools for primary research in various diseases like cancer, infectious disease, rare disease and neurological disease. For instance, in May 2020, The Australian government-funded $21.6 million to support genomics research in cancer and pediatric disease, as well as studies exploring the ethical, legal, and social issues of genomics in healthcare. According to IQ4I research, the infectious disease segment received the highest funding of $xx million during 2019 -2020 mainly due to increase funding by the government for the COVID-19 research. For instance, Genomic Canada launched the Canadian COVID Genomics Network (CanCOGeN) backed by $40 million in federal funding for COVID-19 research. The key players in Genomics Global Market include F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Netherlands), Danaher Corporation. (U.S.), Exact Sciences Corporation (U.S.), Myriad Genetics (U.S.) Bio-Rad Laboratories, Inc. (U.S.), Hologic, Inc (U.S.), Merck KGaA (Germany), Abbott Laboratories (U.S.), BGI Genomics (China) and others. (Added: Wed Nov 18 2020 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Genomics Global Market – Forecast To 2027 - Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes, this also involves the study of interactions between genes and their surrounding environment. It provides significant information to solve biological problems through analysis of genomes using several technologies such as Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In-situ hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT) and others technologies. The genomic data generated by these technologies are helpful in designing personalized medicines, drug discovery, diagnosis, biomarker discovery and in therapy development. According to IQ4I analysis, the genomics global market is expected to grow at mid single digit CAGR from 2020 to 2027 to reach $31,835.9 million in 2027. The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic technologies in drug discovery & development and technological advancements. In addition, the outbreak of global pandemic COVID-19 has shown a sudden surge in demand for genomics-based techniques in the screening of the diseased population. Whereas, factors restraining the market growth are high cost of instruments and special research materials, analytical validity of the result, lack of standardization, complexity, lack of skilled professionals, stringent and time-consuming regulatory guidelines, data security and large data management issues are threats to market growth. The genomics global market is classified into product, application, end-user, and geography. Based on product type, the market is segmented into instruments, consumables, software & services and genomics services. Among the product type, consumables accounted for the largest revenue in 2020 and the market is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics services is fastest growing segment at a high single digit CAGR of from 2020 to 2027 due to increasing pharma companies focus towards the adoption of genetic technologies in the drug discovery & development, increased interest in the development of newer diagnostics, launch of new genomic services and also growing attention toward direct to consumer based genetic tests. In Genomics services, NGS services hold the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics global market is classified based on application into Diagnostics, Drug Discovery& Development, Plant Genomics and Others. Among applications, diagnostics segment accounted for the largest revenue in 2020 and is expected grow at a high single digit CAGR from 2020 to 2027, due to increased incidence of cancer, increased interest in early screening & prenatal screening of genetic diseases, decreasing test cost, the outbreak of various infectious diseases in recent years, reimbursement facility, and advancements in analytical tools. Among the diagnostics sub-segment market, the infectious diseases segment accounted for the largest revenue in 2020 and is expected grow at a mid single digit CAGR from 2020 to 2027. This is attributed to increased application of genomic technology based tests in the detection of pathogen, mainly in outbreak investigations due to its accurate detection. However, the non-infectious disease is fastest growing segment and is expected to grow at a high single digit CAGR from 2020 to 2027. This is attributed to increased application NGS based genetic tests for early screening of cancers & prenatal screening and rapid development of personalized medicine tests for the selection of patients for suitable treatments. The end-users of genomics market is segmented into Pharma & Biotech, Hospital & Clinical Laboratories, Contract Research Organization (CRO's) and others. Among the end-users, Hospital & Clinical Laboratories segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027 attributed to the increasing adoption of early cancer screening tests; increased interest towards NGS based prenatal screening, the outbreak of infectious diseases and reduced testing cost. The Contract Research Organization (CRO's) is expected to grow at a high single digit CAGR from 2020 to 2027 due to increased outsourcing for maximum utilization of genomic technologies in drug discovery process, the launch of new genomic services and increasing capabilities to offer end-to-end genomic services. The genomics global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (RoW). Among various geographies, the North America region dominated the genomics global market with the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. This is due to the increasing R&D expenditure, development and adoption of the latest genomic technologies, presence of major players, increasing use of genomics technologies in early screening, prenatal screening, personalized medicine, reduced testing cost, and crop improvement research and increased funding from private and government agencies. The Asia-Pacific region is the fastest-growing region at a double digit CAGR from 2020 to 2027. This is attributed to the presence of a large number of CROs, growing awareness in the adoption of genomics in early screening, prenatal screening, personalized medicine & crop improvement research, increased government funding towards genomics research & development of companion diagnostics and increased number of start-up & medical genetics companies to develop innovative genomic technologies. Some of the advancements in genomic technologies are the expansion of single-cell biology, advancements in data analysis, databases, integration of machine learning & deep learning, the evolution of third-generation sequencing technology, advancement in genome editing technologies and also emerging CRISPR screening and diagnostics. The advancement of NGS technologies has enabled studying normal biological processes and diseases at a single-cell resolution which helps to clearly understand gene expression, immune profiling and epigenetic mechanisms of single-cell further enhances the application of genomics. For instance, In September 2020, 10x Genomics company launched Chromium Single Cell Multiome ATAC + Gene Expression solution capable of simultaneously profiling the epigenome and transcriptome from the same single cell and also can use this information to precisely engineer more effective immunotherapies in the future. The emerging long-read sequencing (LRS) or third-generation sequencing technologies may provide solutions for improving the characterization of genetic variation and regions that are difficult to assess with the prevailing short-read sequencers (NGS technologies). CRISPR-Cas genome editing technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications and most useful in biomedical research. The speed, simplicity, and precision with which CRISPR-Cas9 technology enables genetic elements to be mutated, silenced, induced, or replaced have resulted in its widespread adoption by the global research community. Also, a plethora of successful CRISPR-Cas-based approaches to detect and diagnose various infectious and non-infectious diseases have been pioneered. Combination of genomics and AI will answer many unresolved questions and opens door for new discoveries. The overall aim is to use AI algorithms to analyze genomic data sets (e.g. associations between variants and molecular or physiological measures of health/disease), which could then provide new parameters for healthcare personalization, identify new disease biomarkers, and refine understanding of disease. Also, the integration of AI into novel genome editing technologies such as CRISPR-Cas provides precise location for DNA alteration and also insights about how to ensure that the repair process of the DNA strand is successful; helping in reducing potential mistakes during the entire process. For instance, Dante Labs is a genetic testing and data analysis company, integrated artificial intelligence (AI) tool to create personalized reports from whole genome sequencing data that leverages a person's medical information to identify the most relevant insights for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. The Genomics market is consolidated with the 6 top players occupying xx% of the market share and the remaining xx% of the market is occupied by other players and service providers. Companies are adopting various organic and inorganic strategies for market expansion. To gain more market share, companies are constantly focusing on developing innovative technologies and differentiated products. For instance, in July 2020, Myriad Genetics, Inc., launched proprietary AMPLIFY technology, to increases the performance of non-invasive prenatal screening (NIPS) tests. In August 2020, Illumina, Inc. launched a new NovaSeq6000 v1.5 Reagent Kits. The new kits bring data-rich applications—such as single-cell genomics, whole-genome sequencing, and liquid biopsy. Genomics is also gaining its importance in the development of precision medicine. NGS-based companion diagnostics paved a new pathway for the selection of candidates for targeted treatment. For instance, in September 2020, Thermo Fisher Scientific received premarket approval from the FDA for an NGS-Based companion diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer. It is the first and only FDA-approved test for targeted treatment for RET fusion-positive NSCLC. Genomic services are gaining importance day by day, so the companies are engaged in the lunch of new genomic services for the maximum utilization of genomics technologies in various applications like drug discovery, diagnosis, crop improvement, etc. For instance, in the COVID -19 pandemic, Eurofins Genomics launched SARS-CoV-2 Full-length Genome Sequencing services aimed at supporting researchers globally in their fight against the COVID-19 pandemic. The service enables accurate identification, strain typing, surveillance of mutational drift and phylogenetic distances between locally and regionally different viral isolate genome sequences. Additionally, several personal genomics startup companies that offer direct to consumer genetic testing are gaining more attention by launching new services. For instance, in February 2020, Nebula Genomics launched a consumer product (30x Whole Genome Sequencing DNA Test) that will offer users whole genome sequencing for $299, Nebula Genomics' whole-genome sequencing analyzes more than 6 billion genetic variants. With this launch, Nebula Genomics also expands its services to 188 countries. These launches mark a dramatic shift in consumer-initiated genetic testing services. It is also estimated that the integration of genomics in the drug discovery process will reduce up to 35% cost and 15% time and with introduction of improved genomics technologies, the savings will be even greater. Pharmaceutical companies have realized the importance of genomics in the drug development process and are incorporating genomics approaches in their drug development process by entering into a strategic collaboration with genomic companies. For instance, in January 2020, Eisai Co., Ltd partnered with Personal Genome Diagnostics to develop a comprehensive liquid biopsy biomarker discovery solution for oncology. Similarly, in February 2020, Atrin Pharmaceuticals collaborated with the Predictive Technology Group to apply genomic analysis to optimize patient selection for Atrin’s upcoming ATRN-119 clinical trial. Predictive is using a genomic database analytics approach to help with patient selection, to increase efficiencies and quality of clinical trials. In developing countries, CROs are showing interest to incorporate genomic services in order to increase service capabilities. For instance, in January 2020, A2 Healthcare Corp. that engages in CRO business in Japan a subsidiary of ITOCHU Corporation entered a capital and business alliance, with iLAC, inc., to launch a whole-genome analysis business. A2 Healthcare will start providing Japan's first pharmaceutical development service that includes whole-genome analysis in collaboration with iLAC. Genomics research was fueled initially by government and nonprofit funding sources, later augmented by private research and development (R&D) funding. According to IQ4I research, during the period 2019-20, approximately $xx million was invested by various companies and government agencies. The funding was received for potential genomics applications, namely disease research, diagnosis, Genetic Risk Assessment, Biomarker Discovery, Crop Improvement, Capacity Expansion, Drug Discovery, Personalized Treatment, AI-based Genomics Platform and Others. The disease research application received the highest funding of $509.4 million from 2019 to 2020 due to increasing investment from the government agencies in the genome sequencing projects and also, development of new genomic tools for primary research in various diseases like cancer, infectious disease, rare disease and neurological disease. For instance, in May 2020, The Australian government-funded $21.6 million to support genomics research in cancer and pediatric disease, as well as studies exploring the ethical, legal, and social issues of genomics in healthcare. According to IQ4I research, the infectious disease segment received the highest funding of $xx million during 2019 -2020 mainly due to increase funding by the government for the COVID-19 research. For instance, Genomic Canada launched the Canadian COVID Genomics Network (CanCOGeN) backed by $40 million in federal funding for COVID-19 research. The key players in Genomics Global Market include F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Netherlands), Danaher Corporation. (U.S.), Exact Sciences Corporation (U.S.), Myriad Genetics (U.S.) Bio-Rad Laboratories, Inc. (U.S.), Hologic, Inc (U.S.), Merck KGaA (Germany), Abbott Laboratories (U.S.), BGI Genomics (China) and others. (Added: Wed Nov 18 2020 Hits: 9 Rating: 0.00 Votes: 0) Rate It

• Genomics Global Market – Forecast To 2027 - Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes, this also involves the study of interactions between genes and their surrounding environment. It provides significant information to solve biological problems through analysis of genomes using several technologies such as Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In-situ hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT) and others technologies. The genomic data generated by these technologies are helpful in designing personalized medicines, drug discovery, diagnosis, biomarker discovery and in therapy development. According to IQ4I analysis, the genomics global market is expected to grow at mid single digit CAGR from 2020 to 2027 to reach $31,835.9 million in 2027. The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic technologies in drug discovery & development and technological advancements. In addition, the outbreak of global pandemic COVID-19 has shown a sudden surge in demand for genomics-based techniques in the screening of the diseased population. Whereas, factors restraining the market growth are high cost of instruments and special research materials, analytical validity of the result, lack of standardization, complexity, lack of skilled professionals, stringent and time-consuming regulatory guidelines, data security and large data management issues are threats to market growth. The genomics global market is classified into product, application, end-user, and geography. Based on product type, the market is segmented into instruments, consumables, software & services and genomics services. Among the product type, consumables accounted for the largest revenue in 2020 and the market is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics services is fastest growing segment at a high single digit CAGR of from 2020 to 2027 due to increasing pharma companies focus towards the adoption of genetic technologies in the drug discovery & development, increased interest in the development of newer diagnostics, launch of new genomic services and also growing attention toward direct to consumer based genetic tests. In Genomics services, NGS services hold the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. Genomics global market is classified based on application into Diagnostics, Drug Discovery& Development, Plant Genomics and Others. Among applications, diagnostics segment accounted for the largest revenue in 2020 and is expected grow at a high single digit CAGR from 2020 to 2027, due to increased incidence of cancer, increased interest in early screening & prenatal screening of genetic diseases, decreasing test cost, the outbreak of various infectious diseases in recent years, reimbursement facility, and advancements in analytical tools. Among the diagnostics sub-segment market, the infectious diseases segment accounted for the largest revenue in 2020 and is expected grow at a mid single digit CAGR from 2020 to 2027. This is attributed to increased application of genomic technology based tests in the detection of pathogen, mainly in outbreak investigations due to its accurate detection. However, the non-infectious disease is fastest growing segment and is expected to grow at a high single digit CAGR from 2020 to 2027. This is attributed to increased application NGS based genetic tests for early screening of cancers & prenatal screening and rapid development of personalized medicine tests for the selection of patients for suitable treatments. The end-users of genomics market is segmented into Pharma & Biotech, Hospital & Clinical Laboratories, Contract Research Organization (CRO's) and others. Among the end-users, Hospital & Clinical Laboratories segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027 attributed to the increasing adoption of early cancer screening tests; increased interest towards NGS based prenatal screening, the outbreak of infectious diseases and reduced testing cost. The Contract Research Organization (CRO's) is expected to grow at a high single digit CAGR from 2020 to 2027 due to increased outsourcing for maximum utilization of genomic technologies in drug discovery process, the launch of new genomic services and increasing capabilities to offer end-to-end genomic services. The genomics global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (RoW). Among various geographies, the North America region dominated the genomics global market with the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. This is due to the increasing R&D expenditure, development and adoption of the latest genomic technologies, presence of major players, increasing use of genomics technologies in early screening, prenatal screening, personalized medicine, reduced testing cost, and crop improvement research and increased funding from private and government agencies. The Asia-Pacific region is the fastest-growing region at a double digit CAGR from 2020 to 2027. This is attributed to the presence of a large number of CROs, growing awareness in the adoption of genomics in early screening, prenatal screening, personalized medicine & crop improvement research, increased government funding towards genomics research & development of companion diagnostics and increased number of start-up & medical genetics companies to develop innovative genomic technologies. Some of the advancements in genomic technologies are the expansion of single-cell biology, advancements in data analysis, databases, integration of machine learning & deep learning, the evolution of third-generation sequencing technology, advancement in genome editing technologies and also emerging CRISPR screening and diagnostics. The advancement of NGS technologies has enabled studying normal biological processes and diseases at a single-cell resolution which helps to clearly understand gene expression, immune profiling and epigenetic mechanisms of single-cell further enhances the application of genomics. For instance, In September 2020, 10x Genomics company launched Chromium Single Cell Multiome ATAC + Gene Expression solution capable of simultaneously profiling the epigenome and transcriptome from the same single cell and also can use this information to precisely engineer more effective immunotherapies in the future. The emerging long-read sequencing (LRS) or third-generation sequencing technologies may provide solutions for improving the characterization of genetic variation and regions that are difficult to assess with the prevailing short-read sequencers (NGS technologies). CRISPR-Cas genome editing technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications and most useful in biomedical research. The speed, simplicity, and precision with which CRISPR-Cas9 technology enables genetic elements to be mutated, silenced, induced, or replaced have resulted in its widespread adoption by the global research community. Also, a plethora of successful CRISPR-Cas-based approaches to detect and diagnose various infectious and non-infectious diseases have been pioneered. Combination of genomics and AI will answer many unresolved questions and opens door for new discoveries. The overall aim is to use AI algorithms to analyze genomic data sets (e.g. associations between variants and molecular or physiological measures of health/disease), which could then provide new parameters for healthcare personalization, identify new disease biomarkers, and refine understanding of disease. Also, the integration of AI into novel genome editing technologies such as CRISPR-Cas provides precise location for DNA alteration and also insights about how to ensure that the repair process of the DNA strand is successful; helping in reducing potential mistakes during the entire process. For instance, Dante Labs is a genetic testing and data analysis company, integrated artificial intelligence (AI) tool to create personalized reports from whole genome sequencing data that leverages a person's medical information to identify the most relevant insights for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. The Genomics market is consolidated with the 6 top players occupying xx% of the market share and the remaining xx% of the market is occupied by other players and service providers. Companies are adopting various organic and inorganic strategies for market expansion. To gain more market share, companies are constantly focusing on developing innovative technologies and differentiated products. For instance, in July 2020, Myriad Genetics, Inc., launched proprietary AMPLIFY technology, to increases the performance of non-invasive prenatal screening (NIPS) tests. In August 2020, Illumina, Inc. launched a new NovaSeq6000 v1.5 Reagent Kits. The new kits bring data-rich applications—such as single-cell genomics, whole-genome sequencing, and liquid biopsy. Genomics is also gaining its importance in the development of precision medicine. NGS-based companion diagnostics paved a new pathway for the selection of candidates for targeted treatment. For instance, in September 2020, Thermo Fisher Scientific received premarket approval from the FDA for an NGS-Based companion diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer. It is the first and only FDA-approved test for targeted treatment for RET fusion-positive NSCLC. Genomic services are gaining importance day by day, so the companies are engaged in the lunch of new genomic services for the maximum utilization of genomics technologies in various applications like drug discovery, diagnosis, crop improvement, etc. For instance, in the COVID -19 pandemic, Eurofins Genomics launched SARS-CoV-2 Full-length Genome Sequencing services aimed at supporting researchers globally in their fight against the COVID-19 pandemic. The service enables accurate identification, strain typing, surveillance of mutational drift and phylogenetic distances between locally and regionally different viral isolate genome sequences. Additionally, several personal genomics startup companies that offer direct to consumer genetic testing are gaining more attention by launching new services. For instance, in February 2020, Nebula Genomics launched a consumer product (30x Whole Genome Sequencing DNA Test) that will offer users whole genome sequencing for $299, Nebula Genomics' whole-genome sequencing analyzes more than 6 billion genetic variants. With this launch, Nebula Genomics also expands its services to 188 countries. These launches mark a dramatic shift in consumer-initiated genetic testing services. It is also estimated that the integration of genomics in the drug discovery process will reduce up to 35% cost and 15% time and with introduction of improved genomics technologies, the savings will be even greater. Pharmaceutical companies have realized the importance of genomics in the drug development process and are incorporating genomics approaches in their drug development process by entering into a strategic collaboration with genomic companies. For instance, in January 2020, Eisai Co., Ltd partnered with Personal Genome Diagnostics to develop a comprehensive liquid biopsy biomarker discovery solution for oncology. Similarly, in February 2020, Atrin Pharmaceuticals collaborated with the Predictive Technology Group to apply genomic analysis to optimize patient selection for Atrin’s upcoming ATRN-119 clinical trial. Predictive is using a genomic database analytics approach to help with patient selection, to increase efficiencies and quality of clinical trials. In developing countries, CROs are showing interest to incorporate genomic services in order to increase service capabilities. For instance, in January 2020, A2 Healthcare Corp. that engages in CRO business in Japan a subsidiary of ITOCHU Corporation entered a capital and business alliance, with iLAC, inc., to launch a whole-genome analysis business. A2 Healthcare will start providing Japan's first pharmaceutical development service that includes whole-genome analysis in collaboration with iLAC. Genomics research was fueled initially by government and nonprofit funding sources, later augmented by private research and development (R&D) funding. According to IQ4I research, during the period 2019-20, approximately $xx million was invested by various companies and government agencies. The funding was received for potential genomics applications, namely disease research, diagnosis, Genetic Risk Assessment, Biomarker Discovery, Crop Improvement, Capacity Expansion, Drug Discovery, Personalized Treatment, AI-based Genomics Platform and Others. The disease research application received the highest funding of $509.4 million from 2019 to 2020 due to increasing investment from the government agencies in the genome sequencing projects and also, development of new genomic tools for primary research in various diseases like cancer, infectious disease, rare disease and neurological disease. For instance, in May 2020, The Australian government-funded $21.6 million to support genomics research in cancer and pediatric disease, as well as studies exploring the ethical, legal, and social issues of genomics in healthcare. According to IQ4I research, the infectious disease segment received the highest funding of $xx million during 2019 -2020 mainly due to increase funding by the government for the COVID-19 research. For instance, Genomic Canada launched the Canadian COVID Genomics Network (CanCOGeN) backed by $40 million in federal funding for COVID-19 research. The key players in Genomics Global Market include F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Netherlands), Danaher Corporation. (U.S.), Exact Sciences Corporation (U.S.), Myriad Genetics (U.S.) Bio-Rad Laboratories, Inc. (U.S.), Hologic, Inc (U.S.), Merck KGaA (Germany), Abbott Laboratories (U.S.), BGI Genomics (China) and others. (Added: Wed Nov 18 2020 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• Morelia Clinic is the El Monte Health Clinic that can Cater to All Your Medical Needs - El Monte – California –USA- 17.11.2020 – Health care facilities are better in USA compared to most other nations in the world. This however does not eliminate the healthcare problems encountered by people in the country. The story is the same for El Monte and the State of California. People in all sectors of the society face different health related issues including the Covid19 pandemic infections. Until recently the patients depended on the general or family doctors El Monte especially when they required primary care El Monte. Even that trend is steadily changing as people are now looking for a clinic that can provide primary care as well as specialist healthcare services. When it comes to such requirement the Morelia Clinic stands out as the best El Monte health clinic that can take care of all types of medical needs of the patients including primary care El Monte. The clinic also houses in its wings the best OBGYN doctor El Monte as well as other specialist doctors. In short; the clinic stands out as the single window solution for all your health related requirements. Even the family doctors El Monte are referring their patients to Morelia Health Clinic as it is the most trusted health clinic in El Monte and California. One of the unique features of the El Monte health clinic is that it meets all the necessities for countering the recent Covid19 pandemic. It has a completely segregated unit for dealing with Covid19 patients. Best doctors in the clinic take care of recent health syndrome maintaining all the precautions necessary in such treatments. The clinic also houses best specialist doctors like the OBGYN doctor El Monte and you won’t have to search for either the general doctor or specialist doctor that can give you the best possible healthcare services in El Monte and California. “If you are searching for best health services for you and your entire family then Morelia Clinic is the right place to approach. Our highly proficient doctors and support staff can provide the exact type of healthcare services including primary care El Monte as well as specialist services matching your requirements and budget”, says a senior doctor in the clinic. “We also have the best specialists in healthcare industry in California including the OBGYN doctor El Monte ending your search for the best healthcare provider”, she concluded. About Morelia Clinic Morelia Clinic is El Monte in California based Family Medical Clinic / Medical group. The El Monte health clinic has worked as a total solution on healthcare services for the entire family of the clients. Over the years its reputation as the best clinic around has increased considerably. Most of the family doctors El Monte also use it as referral center for advanced treatments of the patients. ===================== Contact Information Morelia Medical Clinic 'Morelia Clinic" 3030 Tyler Ave, El Monte, CA 91731 ‎ Phone: (626) 350-9540 Email: VistasolMedicalGroup@gmail.com Our other Clinic: "Vistasol Medical Group" 1000 W Whittier Blvd Montebello, CA 90640 Phone: (323) 346-0555 (Added: Tue Nov 17 2020 Hits: 9 Rating: 0.00 Votes: 0) Rate It

• Research shown Apogen® can inhibit SARS-Cov-2 Coronavirus in cellular model - The COVID-19 epidemic continues to ravage the world, with a total of 44 million infections worldwide so far, while there are still nearly 400,000 confirmed cases in Europe and the United States every day. Since the outbreak of the epidemic, FEBICO(Far East Bio-Tec Co., Ltd.) has been cooperating with Chang Gung University's Emerging Virus Infection Research Center to conduct in vitro study to evaluate the inhibition of different types of coronaviruses. It was found that Apogen® can effectively inhibit the 229E coronavirus, as well as SARS-CoV2, COVID-19 with significant inhibitory activity (Figure 1) The study was conducted by a standard plaque reduction assay to evaluate the inhibitory effect of Apogen®. In each well, 2x106 Vero E6 cells/wall was seeded and grow to 95% confluency. Apogen® is then added to each group. There are six groups in total to determine the concentration which can achieve 50% virus inhibition: virus group, virus group with Apogen® at 50 ug/ml, 100 ug/ml, 250 ug/ml, 500 ug/ml, 1000 ug/ml. Each group is conducted in triplet. After treatment, each cell is incubated for another hour and wash with PBS buffer to remove unattached virus. Each well is then treated with agarose gel with nutrient to allow the cells to grow for 3 days. At the end of 3 days, cells are fixed with paraformaldehyde and stained with crystal violet to determine the viability of cells. Result and discussion: As violet blue only stains for the DNA of viable cell. The unstained, white spots indicated the death of cells due to viral infection and is recognized as viral plaque. Apogen® can inhibit SARS-CoV-2 virus infection in cellular level. SARS-CoV-2 can be inhibited completely at 250 ug/ml and 70% can be inhibited at 100 ug/ml. The result demonstrates that Apogen® can be a promising agent for SARS-CoV-2 intervention and prevention. Comparing with the previous study of Remdesivir, an adenosine analogue, EC50 of Remdesivir is 0.77 μM. The inhibitory mechanism of remdesivir is through incorporation into nascent viral RNA strands which results in premature termination. However, Remdesivir through clinical trials was found to be more effective to Caucasians and people with mild symptoms, while Asians and patients with advanced disease progression received little to no therapeutic effect. In addition, liver failure is a common side effect for Remdesivir treatment. Conclusion FEBICO has been developing antiviral drugs for more than 20 years and recently discovered that the main drug ingredient, Apogen®, has a significant inhibitory activity against the new coronavirus (SARS-CoV2, COVID-19) according to in vitro study. The discovery of this cellular experiment is a beginning for SARs-Cov-2 inhibition. Through FEBICO’s long-term commitment to anti-viral development, we are seeking clinical partners to co-develop antivirus product and bring contribution to the globe in this pandemic. (Added: Mon Nov 16 2020 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Will it be able to select the healthcare training school simply? - Summary-selecting the best health care training school will not be that much easy you need to take a lot of surveys from different training schools that are available in the market and selecting the one among that and the one that you think will be good for your career support has to be chosen. How to choose them? If you feel like that the training school is not good for your use then you can change to the other without having any sort of confusion. If somebody asks you about where they can find the best healthcare training schools near me you can explain to them the choice that you have taken before for you. Type of course that you are planning to learn You need to know about the course that you are willing to learn and also you have to mention the specification in it so that you will be forwarded to that particular training center. When you make use of the phlebotomy courses raleigh nc that will provide you the best service and also be more flexible to their students. Training Before you select the training center you need to know about the training that the center provides you make sure that the training contains only the experienced professionals who will guide you in the right way. In that way when you take the AHA CPR Training Raleigh this will contain a lot of professionals where you can gain a lot of knowledge from the help of them. Final thoughts It is very important to go for the right training so that it will be good support for you when you join work in the future and also this will help develop your knowledge to know about everything unknown to you. (Added: Thu Nov 12 2020 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• The Importance of Gifting Sweets in Diwali - Well, the connect of Diwali celebrations and sweets is extremely close. Most of India cannot think of a Diwali without sweets or mithais. Though the kind of celebration may differ but sweet is an integral part of Diwali celebrations every year. This year due to the pandemic though new restrictions are being levied about Diwali celebrations but sweet distribution or mithai for corporate gifting in Vadodara and rest of India remains unchanged. In this blog, lets learn how sweets became an inevitable parts of Diwali celebrations: Connect with Ramayana and Mahabharata Diwali celebrations are often believed to originate from the stories of Ramayana and Mahabharata. For Ramayana, Diwali is believed to commemorate the return of Lord Rama, his wife Sita and brother Laxman returned from 14-years exile. In Mahabharata, the return of Kauravas marks as celebration of Diwali. In both the occasions, the people of Ayodhya and Hastinapur were very happy and thus, celebrated by illuminating their houses and giving away sweets. The same practice of distributing sweets on the joyous occasion of Diwali still continues. HanuRam Foods Pvt. Ltd. offers chocolate mithai in Vadodara. Commemorate wedding anniversary of Goddess Lakshmi and Lord Vishnu Another age-old tradition is, Diwali marks the wedding anniversary of Goddess Lakshmi and Lord Vishnu. When they got married the gods got extremely happy about it and is believed to have distributed sweets. This also makes sweets an integral part of Diwali celebrations. If looking for Diwali sweets in Vadodara, HanuRam Foods Pvt. Ltd. is a great choice. Harvest season for farmers Diwali also marks the end of harvest season for farmers. Farmers being happy about their crops and plentiful bounty celebrates by sharing sweets. Such a custom has also made sweets a must in Diwali celebrations across India. These are just a few stories that relate sweets and its role in Diwali celebrations. Some also relate it to the victory of Lord Vishnu over Mahabali. Now you can buy mawa mithai in Vadodara at HanuRam Foods Pvt. Ltd. HanuRam Foods Pvt. Ltd also offers mithai delivery in Vadodara. (Added: Thu Nov 12 2020 Hits: 9 Rating: 0.00 Votes: 0) Rate It

• ‘Exer-tainment’ exercising will launch your new year fitness goals in 2021! - Avoid ‘Quitter’s Day’ on Jan 19th by trying this unique entertainment-driven adventure fitness app – Apocalypse Survival Training As January looms everyone is looking ahead to those new year resolutions it annually bestows. Health and fitness is set to top 2021’s list, with a YouGov poll confirming 50% of people stating their top resolution is to exercise more. Last year Strava analysed over 800m of their user-logged activities and now predicts the day most people are likely to give up on their new year resolutions is January 19 (they call it Quitter’s Day). So, it’s challenging enough, without adding Covid-19, screen fatigue for virtual workouts and those who are struggling to exercise under the new restrictive measures. Successfully returning to health this January will be much more challenging than usual, so people need something unique and inspiring to achieve this once the January blues hit. Enter Adele Andersen, fitness expert, bootcamp instructor, passionate geek and founder of the ‘Apocalypse Survival Training’ app. Her mission is to make exercising more fun and rewarding by fusing story-lead entertainment with exercise routines for positive results. Apocalypse Survival Training does this through its gripping storyline, set in an alternate reality London, where each user is guided by team of trainers to save the world from an alien invasion one workout at a time. Unlike other apps in this market, it stands out for having full length audio drama through its episodes – instead of padding the story with the user’s playlist – full and expert coaching from start to finish, three types of workout (running, bodyweight circuit training and yoga/stretch) and is produced so that it sounds like the user is in a three dimensional audio space with the other characters – and aliens! – around them, creating a uniquely immersive experience. The other key to Apocalypse Survival Training’s popularity is the characters. Adele explains “I wanted to make sure most people who use the app feel represented by the characters, so as with our users, we have some who love to workout, and some who don’t have a great relationship with exercising. But because they’re all thrown into this invasion storyline, we have to coach some characters through that – while challenging others – meaning we’re also coaching to all user levels – and attitudes!” She adds, “So it is the perfect app for those who need, or want, to try something a little different this Jan to get them through the hump that comes after the initial excitement and motivation of New Year’s resolutions wear off. All you need is your mobile, headphones and an adventurous spirit to get started!" Apocalypse Survival Training app is available to download via the App Store and Google Play store, you can try episode 1 for free and then continue your mission by purchasing single episodes or a package (£6.99 for the first 10 episodes or £0.99 per episode, or unlock a £5.99 special offer at the end of Episode 1). (Added: Thu Nov 12 2020 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• Sucessful Liver Transplantation for Sri Lankan Professor at Dr. Rela Institute, Chennai - Sri Lankan Professor Undergoes Liver Transplant From An Accidental Donor, Amid Covid Lockdown at Dr Rela Institute & Medical Centre (RIMC). The transplant is done with the patient’s brother-in-law coming forward to donate a part of his liver, at the last minute. crux of the story - A 44 year-old professor with the Ministry of Science, Technology and Research, Government of Sri Lanka professor came along with his wife as his donor for liver transplant. During the wife's examination, we diagnosed her with a "low-grade tumour" arising from the small intestine making her medically unfit for being a donor. Since his wife, who was also treated for her condition here, could not donate the liver,his brother-in-law came forward to be a living liver donor at the last moment. A nine-hour long surgery was done "successfully" on September 24 on the Sri Lankan national and "post-surgery, both the donor and the patient recovered well (Added: Wed Nov 11 2020 Hits: 7 Rating: 0.00 Votes: 0) Rate It

• Everything Seniors Need To Know About Preventing Glaucoma - There’s no denying that vision loss is common with age. Glaucoma can be attributed to be the main cause of about 10 percent of total blindness in the United States, and majority of people affected are seniors (individuals over 65 years of age). While on one hand glaucoma is one of the leading causes of legal blindness in the US that leads to irreversible vision loss-and eventually can cause complete blindness, it is also probably the most preventable cause of vision loss. Healthy vision is the key to living a quality life, even more so in your senior years. It not just reduces the probability of silly accidents, but also makes people more self-sufficient, and boosts their confidence to navigate the indoors and outdoors. Glaucoma and cataracts are common vision problems seniors are most likely to develop, which can occur in one or both eyes, simultaneously. This article aims to discuss the ways you can prevent the former. About three million Americans have glaucoma, but only about half of them realize it, which is what leads to 9-12 percent of all cases of blindness. Glaucoma is a cluster of diseases that can damage the eye’s optic nerve, and is also referred to as a silent disease as many people may not be aware that they have it. The disease can be caused by an increased pressure within the eye that damages the optic nerve. Without increased eye pressure also, glaucoma can develop in someone. Symptoms: As has already been mentioned, many people can have the disease without any symptoms or vision changes. As the disease advances, there might be a gradual loss of peripheral vision, meaning that over time, the vision out of the side of the eyes will start to worsen and appear as if you are looking through a tube or tunnel. The best way to detect the disease is with a comprehensive dilated eye exam. It must be noted that glaucoma- if goes undiagnosed and untreated- causes more vision loss than any other disease in the world. This is also where the good news lies, which are vision loss as a result of glaucoma can be prevented with early diagnosis and treatment. Common types of glaucoma in older adults: 1.Is open-angle Glaucoma (this is the most common type) 2.Withopen-angle 3.Low-tension or normal Tension Glaucoma (this type is more difficult to detect) 4.From angle-closure Some rare types include Pigmentary Glaucoma (mostly affects nearsighted people and men) and Trauma-related Glaucoma (which mainly develops due to any serious blow to the eye, chemical burn, etc.). Although there is no cure for glaucoma, currently, regular eye exams are the best form of prevention against significant damage from the disease. Generally, a check for glaucoma should be done every 2-4 years before age 40, every 1-3 years from age 40-54, every 1-2 years from age 55-64, and every 6-12 months after age 65. If the physician detects signs of glaucoma, they will work towards lowering the pressure in the eye, which usually begins with eye drops but may as well include other treatment options, such as oral medications, surgery, or lasers. Remember, timely diagnosis and appropriate treatments are key to preventing the disease. Risk factors: The key for seniors to lower their risk for developing this common vision issue is by knowing the risk factors and taking steps to minimize those that are preventable. The risk factors include 1.Age 2.Genetics 3.Steroids (long-term steroid use) 4.Eye injury 5.High blood pressure 6.Diabetes 7.Migraines 8.Poor blood circulation These tips can help seniors protect their eyesight and prevent glaucoma from developing or progressing: 1Wear eye protection, especially when going to areas with heavy traffic, while playing sports, etc. to protect against serious eye injuries. 2.Exercise regularly to lower your eye pressure. 3.Taking prescribed medication can help prevent glaucoma from progressing. 4.It is important to maintain normal blood pressure and insulin levels. 5.Make sure to attend regular doctor visits. If your senior loved one has been suffering from vision-related issues that have made it challenging to carry out day-to-day activities, it is best to go for a seniorhome care Charlotte, NC professional for your house, who’ll provide round-the-clock support to your beloved and allow him/her to live their best quality of life. For more info, check out: https://www.arogahomecare.com (Added: Wed Nov 11 2020 Hits: 9 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... [>>]